Potentially Inappropriate Medications Involved in Drug–Drug Interactions in a Polish Population over 80 Years Old: An Observational, Cross-Sectional Study
Emilia Błeszyńska-Marunowska, Kacper Jagiełło, Łukasz Wierucki, Marcin Renke, Tomasz Grodzicki, Zbigniew Kalarus, Tomasz Zdrojewski

TL;DR
This study examines drug interactions and inappropriate medications in Polish seniors over 80, finding that automated analysis can improve treatment safety when combined with clinical judgment.
Contribution
The study provides up-to-date data on PIMs and DDIs in Polish elderly patients and highlights the importance of clinical verification in reducing inappropriate drug combinations.
Findings
DDIs were detected in 66.9% of the study group, while PIMs were detected in 94.4%.
Clinical verification reduced DDIs by over 1.5 times and interactions requiring therapy modification by nearly 3 times.
Painkillers, psychiatric, and neurological drugs were the most common PIMs involved in DDIs.
Abstract
The clinical context of drug interactions detected by automated analysis systems is particularly important in older patients with multimorbidities. We aimed to provide unique, up-to-date data on the prevalence of potentially inappropriate medications (PIMs) and drug–drug interactions (DDIs) in the Polish geriatric population over 80 years old and determine the frequency and the most common PIMs involved in DDIs. We analyzed all non-prescription and prescription drugs in a representative national group of 178 home-dwelling adults over 80 years old with excessive polypharmacy (≥10 drugs). The FORTA List was used to assess PIMs, and the Lexicomp® Drug Interactions database was used for DDIs. DDIs were detected in 66.9% of the study group, whereas PIMs were detected in 94.4%. Verification of clinical indications for the use of substances involved in DDIs resulted in a reduction in the total…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Practices and Patient Outcomes · Medication Adherence and Compliance · Blood Pressure and Hypertension Studies
